Transdermal endoscopic sacral nerve stimulation - endoscopic parasacral nerve stimulation as treatment for fecal incontinence

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00000238

Enrollment

Registered

2009-10-14

Start date

2011-06-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R15

Interventions

Group 1: endoscopic percutaneous implantation of a stimulation elektrode

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: ->18 years -neurogenic fecal incontinence -muscular fecal incontinence: only small lesion of the sphincter (max. 1/4 of circumference -Anatomy of the os sacrum, that complicates or prohibits standard-SNS -signed informed consent

Exclusion criteria

Exclusion criteria: -<18 years -primary neurologic degenerative reason for fecal incontinence -coagulopathy -infectons like pneumonia, infection of the urinary tract, infection of soft tissue with danger of bacteriemia -rectal surgery via abdominal access -pregnancy

Design outcomes

Primary

Measure	Time frame
-positive peripheral nerve evaluation via electromyogram \|\| -number of indications for permanent SNS \|\| -clinical response to tSNS (temporare SNS): clinical and a significant subjective improvement for the patient (stool diary-score and Wexner-score)	—

Secondary

Measure	Time frame
-number of complications \|\| -duration of intervention \|\| -improvement of anal compression (anal manometry) \|\| -improvement of concomitant urinary incontinence	—

Countries

Germany

Contacts

Public ContactMatthias Goos

Universitätsklinikum Freiburg Abteilung für Allgemein- und Viszeralchirurgie

matthias.goos@uniklinik-freiburg.de0761-270/2401

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026